pharmaphorum

JULY 29, 2021

It’s estimated specialty medications account for 75% of the approximately 7,000 prescription drugs currently in development, and by 2022, more than 60% of the 600 drugs expected to gain FDA approval will be specialty medications. The problem is, many specialty pharmacies don’t currently have the right tools to support their patients.

Pharmacy 111

Pharmacy Drugs FDA Approval Marketing 111

Drug Channels

MARCH 27, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. The rise of discount card pricing within pharmacy benefit plans is a positive development. Links below.

Pharmacy 98

Pharmacy Drugs Marketing Generic Drugs 98

Pharmaceutical Technology

FEBRUARY 27, 2025

Vietnam is aiming to attract overseas investment to encourage domestic drug development through the amended 2016 Law on Pharmacy.

Pharmacy 147

Pharmacy Development Drugs Marketing 147

Drug Channels

NOVEMBER 15, 2022

The rise of discount card pricing within pharmacy benefit plans is a positive development. However, I suspect few people understand that placing discount cards within the pharmacy benefit enables a PBM to monetize a new fee stream from the card vendor. Links below.

Pharmacy 98

Pharmacy Drugs Marketing Generic Drugs 98

Drug Channels

JULY 20, 2022

In this issue: CVS disassociates itself from its chain pharmacy association Payers are paying attention to ICER Benefits of the biosimilar boom A fantastic takedown of health insurance deductibles Plus, I join the Advisory Board of Alto Pharmacy. Cut through the steamy summer haze with our refreshing selection of articles and insights.

Pharmacy 98

Pharmacy Drugs Marketing Development 98

Drug Channels

MAY 23, 2023

Below, you’ll find Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share based on equivalent prescription claims. I also provide commentary on recent market developments and offer some helpful tips for interpreting the figures. to 1:30 p.m.

Pharmacy 98

Pharmacy Marketing Drugs Development 98

Drug Channels

APRIL 5, 2022

Consider Drug Channels Institute's latest estimates of pharmacy benefit manager (PBM) market share, shown in the chart below. I’ll examine DCI’s latest PBM market data, the emergence of PBM purchasing groups, specialty market developments, PBMs’ evolving compensation models, and much more. Click here for more details.

Pharmacy 98

Pharmacy Marketing Drugs Development 98

Medical Xpress

APRIL 27, 2023

A new test revealed that FDA-approved antibiotics—available at your neighborhood pharmacy—can effectively treat superbugs. The new test may improve the way antibiotics are developed, tested and prescribed—and it is openly available to all. They are not prescribed, however, because the gold-standard test predicts they will not work.

Pharmacy 87

Pharmacy FDA Approval Development Research 87

Pharmaceutical Technology

JULY 20, 2022

In response to these issues, American Society of Health-System Pharmacists senior director of Pharmacy Practice and Quality Michael Ganio tells Pharmaceutical Technology : “Pharmacists are going to address [these concerns] by doing what we've always done. Paxlovid in the news.

Pharmacy 278

Pharmacy Licensing Licensing Drugs 278

Pharmaceutical Technology

MARCH 10, 2023

It is a third-generation, selective and structurally unique, small molecule CGRP receptor antagonist and is currently under clinical development with oral and intranasal formulations. The company expects to launch Zavzpret in pharmacies in July.

FDA Approval 246

FDA Approval Pharmacy Trials Clinical Development 246

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that involves not only scientific and medical expertise but also adherence to strict legal and ethical standards. This article will delve into the importance of scientific expertise in generic drug development, highlighting the key areas where scientific knowledge is essential.

Generic Drugs 98

Generic Drugs Bioequivalency Development Drugs 98

pharmaphorum

JUNE 8, 2022

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being formally investigated by the Federal Trade Commission (FTC). The post FTC launches probe into pharmacy benefit management sector appeared first on.

Pharmacy 64

Pharmacy Medicine Drugs Manufacturing 64

Pharma Mirror

NOVEMBER 21, 2020

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its antiepileptic medications, with greater capabilities to expand across additional brands. 1 in 26 people in the US will develop epilepsy at some point in their.

Development 130

Development Branding Doctors Doctor 130

World of DTC Marketing

NOVEMBER 22, 2021

In the words of the company’s mission , its goal is to “make high-quality health and pharmacy services safe, affordable and easy to access.” Amazon is developing AI models for surgery which “has the potential to reduce cost and complications of certain surgeries by 40 to 50%.

Pharmacy 241

Pharmacy Nurses Doctors Doctor 241

XTalks

JUNE 4, 2024

In the ever-evolving landscape of pharmaceutical development, the complexity of early phase clinical trials is increasing. This surge in complexity is driven by escalating drug development costs, heightened competition and advanced scientific innovations. And that has a lot of downstream consequences.” This trend, which Dr.

Clinical Development 110

Clinical Development Development Clinical Trials Clinical Trials 110

Pharmaceutical Commerce

AUGUST 9, 2023

Stephanie Smith Cooney joins PBM business to further develop partnerships, especially with independent pharmacists in local communities.

Pharmacy 98

Pharmacy Development 98

Worldwide Clinical Trials

FEBRUARY 21, 2024

During clinical development, new chemical entities (NCEs) require an absorption, metabolism, and excretion (AME) study. Dosing Our pharmacy services can prepare liquid, solid, and intravenous dosage formulations. To accomplish this, we pay careful attention to both dosing and sample collection.

Clinical Trials 200

Clinical Trials Clinical Trials Pharmacy Trials 200

Outsourcing Pharma

MAY 24, 2021

The owner of the pharmacy giant has announced plans to partner with various stakeholders in an effort to effect improvements across the trial ecosystem.

Clinical Trials 140

Clinical Trials Clinical Trials Trials Pharmacy 140

Pharmaceutical Technology

JULY 25, 2022

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. The FDA knows that developing specialty generics, particularly generic injectable products, can be challenging. The only way forward for generics producers.

Drugs 298

Drugs Manufacturing Production Marketing 298

XTalks

NOVEMBER 7, 2024

Journey Medical plans to make Emrosi available by early 2025 through dermatology clinics and pharmacies across the US. Maraoui said the company’s dermatology-focused sales force is “now preparing for a successful launch and to establish Emrosi as a new standard of care in the treatment of rosacea.”

FDA Approval 105

FDA Approval Dermatology Bacteria Clinical Trials 105

Drug Channels

MARCH 4, 2025

for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Pharmacies and Pharmacy Benefit Managers , Dr. Fein will provide invaluable insights to help you and your team stay informed about this rapidly evolving market. Fein, Ph.D.,

Pharmacy 98

Pharmacy Drugs Branding Marketing 98

Outsourcing Pharma

APRIL 19, 2024

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

Pharmacy 86

Pharmacy Manufacturing Production Development 86

Drug Channels

MARCH 26, 2025

ET, as he shares his expert analysis on critical industry developments. P.S. Join my more than 61,000 LinkedIn followers for daily links to neat stuff along with thoughtful and provocative commentary from the DCI community. Join Adam J. Fein, Ph.D., on April 4, 2025, from 12:00 p.m. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 52

Pharmacy Drugs Development 52

Pharma Mirror

OCTOBER 1, 2022

These are: “Chronic respiratory diseases — A handbook for pharmacists”; and “Knowledge and skills reference guide for professional development in chronic respiratory diseases”.

Pharmacy 130

Pharmacy Development 130

Pharmaceutical Technology

SEPTEMBER 7, 2022

Pharmaceutical benefit managers and management companies serve as intermediaries between insurance companies, pharmacies, and drug manufacturers. They bring together employers/plan sponsors, health insurers, plan members, drug wholesalers, pharmacies, and drug companies to facilitate better health outcomes at an affordable cost.

Pharmacy 100

Pharmacy Containment Manufacturing Compliance 100

Pharmaceutical Technology

JULY 7, 2022

Although a high number of cell and gene therapies are in early-stage development, a new wave of approvals could be on its way. Another seven CAR-T therapies are in the pre-registration stage, meanwhile there are currently 266 CAR-T cell therapies in Phase II-III development, according to GlobalData. Securing the supply chain.

Gene Therapy 245

Gene Therapy Gene Medicine Genetics 245

pharmaphorum

SEPTEMBER 22, 2020

A UK university has struck a partnership with medical technology firm Better that aims to give nursing and pharmacy students a better insight into e-prescribing. In the pharmacy school, the system will be used by final year students and post-graduates.

Pharmacy 111

Pharmacy Nurses Medicine Production 111

pharmaphorum

DECEMBER 21, 2021

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

Pharmaceutical Technology

SEPTEMBER 7, 2022

They also partner with retail pharmacy chains, pharmacy network aggregators, and consumer behaviour data companies on behalf of pharmaceutical manufacturers to collect data for sourcing patient information.

Pharmacy 130

Pharmacy Containment Manufacturing Compliance 130

World of DTC Marketing

FEBRUARY 28, 2021

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. So should we forget all that because they developed a COVID vaccine? The answer is NO.

Vaccine 180

Vaccine Vaccination Contamination Compliance 180

FDA Law Blog

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ). 2, 2020 ( DOJ Press Release ).

Pharmacy 52

Pharmacy Regulation Sales Production 52

XTalks

JUNE 8, 2023

The selection of a contract research organization (CRO) to support a cell or gene therapy program is crucial during the product’s development, as it can determine the success or failure of a study in meeting timelines and gathering the necessary data for approval. Another integral element is timeline management. .”

Gene Therapy 98

Gene Therapy Gene Production Development 98

Pharmaceutical Technology

MAY 24, 2023

Whilst the pharma industry has been relatively slow in developing new treatments – an array of legal challenges posed to pharma companies and pharmacies implicated in the crisis still trundles on. The year 2023 has seen some landmark regulatory developments to contain the crisis.

FDA Approval 147

FDA Approval Pharmacy Pharma Companies Containment 147

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. What is a Drug Patent?

Medicine 97

Medicine Drugs Production Development 97

XTalks

MARCH 17, 2025

Roche, a global leader in biotechnology and diagnostics, has entered into an exclusive collaboration and licensing agreement with Zealand Pharma, a specialist in innovative therapeutics, to co-develop and co-commercialize petrelintide as a potential foundational therapy for people with overweight and obesity. billion $1.4

Hormones 59

Hormones Drugs Sales Insulin 59

Pharmaceutical Technology

OCTOBER 31, 2022

The investigational ophthalmic formulation of bevacizumab, ONS-5010 is currently being developed as an intravitreal injection to treat wet AMD and other retinal diseases. It is also developing registration documents for approvals in Europe, with submission expected in the fourth quarter of this year.

FDA Approval 147

FDA Approval Pharmacy Licensing Licensing 147

Pharmaceutical Technology

APRIL 26, 2023

Dr. Amy Chan, senior clinical research fellow at the School of Pharmacy, University of Auckland, says digital inhalers have existed for almost 30 years. Electronic respiratory health company Adherium has also developed a digital inhaler system focusing on patient adherence, remote monitoring, and data management.

Clinical Trials 289

Clinical Trials Clinical Trials Research Allergies 289